{"id":409,"date":"2023-12-07T14:16:47","date_gmt":"2023-12-07T20:16:47","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/chromosome-18\/?page_id=409"},"modified":"2024-01-17T10:25:03","modified_gmt":"2024-01-17T16:25:03","slug":"our-program","status":"publish","type":"page","link":"https:\/\/wp.uthscsa.edu\/chromosome-18\/our-program\/","title":{"rendered":"Our Program"},"content":{"rendered":"

[vc_row][vc_column width=”2\/3″][vc_column_text]The Chromosome 18 Clinical Research Center is conducting a life-time longitudinal study of \u00a0individuals with any chromosome 18 abnormality with the goal of improving their health and life.<\/p>\n

Eligibility<\/h2>\n

Any individual of any age with a previously diagnosed chromosome 18 abnormality. This includes a diagnosis of 18p-, 18q-, Ring 18, Tetrasomy 18p, Trisomy 18, a chromosome 18 inversion or translocation. These genetic changes can be as small as involving a single gene on chromosome 18.<\/p>\n

Program Design<\/h2>\n

This is a life-time longitudinal study. Individuals who have completed the Primary Enrollment are then offered the opportunity to \u00a0participate in other research activities.<\/p>\n

Primary Enrollment<\/h4>\n

The Primary Enrollment involves first providing the diagnostic laboratory report that detected the chromosome 18 abnormality. Then discussing the program with the Program Manager, reading and then signing the informed consent documents. Sending other relevant medical records. Then we will send \u00a0you a kit for getting blood drawn on the person with a chromosome 18 abnormality and both of their biological parents (when available).<\/p>\n

Subsidiary Studies<\/h4>\n

A participant must have completed the Primary Enrollment in order to be eligible to participate in any of these or future studies. These studies \u00a0could include:<\/p>\n